Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|October 8, 2022
Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapyJoanne S Evans, Jamie Beaumont, Marta Braga, et al.
Oncology|September 18, 2017
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular CarcinomaDavid J Pinato, Marco Merli, Alessia Dalla Pria, et al.
Scientific Reports|June 13, 2018
Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trialSurendra Kumar Sharma, Alladi Mohan, Achintya Dinesh Singh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 11, 2022
Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular CarcinomaMei Ran Abellona U, Eric Yi-Liang Shen, Caroline Cartlidge, et al.
Intestinal Research|May 20, 2017
Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosisSuraj Kumar, Sawan Bopanna, Saurabh Kedia, et al.
Neuroendocrinology|February 26, 2020
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine TumoursDavid J Pinato, Anu Vallipuram, Joanne S Evans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2016
Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine TumorsSuraiya R Dubash, Nicholas Keat, Paola Mapelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxelKaiyumars B Contractor, Laura M Kenny, Justin Stebbing, et al.
Oncotarget|June 1, 2016
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative studyDavid J Pinato, Tadaaki Arizumi, Jeong Won Jang, et al.
Oncotarget|February 18, 2017
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenibJessica Howell, David J Pinato, Ramya Ramaswami, et al.
Pageof 17